London, England (June 15, 2018) – Dr. Eliaz Babaev, Arobella’s president & CEO, was a keynote speaker at the International […]

Minneapolis, Minn.(June 25, 2016) – In accordance with Health Canada Medical Devices Regulations, Section 36, Arobella Medical, LLC issued Medical […]

Minneapolis, Minn. (May 16, 2014) – Arobella Medical, LLC received new FDA 510(k) clearance (K131096) for the Qoustic Wound Therapy […]

Seattle, WA (November 6, 2013) – Arobella showcased and presented the new ultrasound wound therapy hand piece for the Qoustic Wound […]